CEGE

Cell Genesys terminates Phase III prostate cancer trial - 08/29 - 05:03 AM ET

Cell Genesys terminates Phase III prostate cancer study - 08/28 - 12:07 PM ET

Stockwire.com: Cell Genesys, Inc. (Nasdaq:CEGE) just released some important news. - 08/28 - 11:06 AM ET

Cell Genesys Finishes At New Low - 08/27 - 04:18 PM ET

Shares of Cell Genesys Tumble After Halting Gvax Trial - 08/27 - 11:40 AM ET

CELL GENESYS HITS ALL-TIME LOW OF 69C IN INTRADAY TRADES - 08/27 - 09:44 AM ET

CELL GENESYS PLUMMETS 74% TO 73 CENTS; TERMINATES PHASE III TRIAL - 08/27 - 09:43 AM ET

CELL GENESYS VOL 3.4M VS 30-DAY AVG VOL 844,032 - 08/27 - 09:43 AM ET

CEGE: Conference call regarding Cell Genesys Halts VITAL-2 GVAX Trial in Advanced Prostate Cancer @ 08:30 ET Today [delayed] - 08/27 - 08:57 AM ET

Cell Genesys Declines In Pre-Market On Termination Of Advances Prostate Cancer Drug Trial - 08/27 - 08:31 AM ET

Cell Genesys ends second of two Phase III trial for prostate cancer treatment - 08/27 - 07:19 AM ET

CELL GENESYS TERMINATION RECOMMENDED BECAUSE OF IMBALANCE OF DEATH - 08/27 - 07:16 AM ET

CELL GENESYS TRIAL TERMINATION RECOMMENDED BY IDEPENDENT MONITORING COMMITTEE - 08/27 - 07:15 AM ET

CELL GENESYS TERMINATES VITAL-2 PHASE 3 GVAX TRIAL FOR PROSTATE CANCER - 08/27 - 07:14 AM ET

Cell Genesys Halts VITAL-2 GVAX Trial in Advanced Prostate Cancer - 08/27 - 07:10 AM ET

CEGE: To Present At Canaccord Adams Global Growth Conference @ 09:30 ET [delayed] - 08/12 - 07:53 AM ET

CELL GENESYS 2Q NET LOSS 3C VS 3C - 08/01 - 04:03 PM ET

CEGE: Q2 Earnings Call @ 16:30 ET Today [delayed] - 08/01 - 01:50 PM ET

Cell Genesys' Final Results From Phase 2 Clinical Trial of GVAX Immunotherapy Published - 07/27 - 11:34 PM ET

Cell Genesys to Webcast Second Quarter 2008 Conference Call - 07/25 - 08:30 AM ET

Page 1 of 7     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index